CYP7B1 helps the body process certain cholesterol byproducts so it can make bile acids, which support fat digestion, and keep some nerve tissues balanced. If the CYP7B1 gene does not work properly, these substances can build up and affect the liver or nervous system. Pathogenic variants in the CYP7B1 gene are linked to a bile acid condition that can appear in infancy and to an inherited condition that often causes gradually increasing leg stiffness and weakness.
What is a gene?
Genes are stretches of DNA that carry instructions cells use to make molecules or regulate processes throughout the body. Some genes provide the directions for producing proteins, which are the functional components of cells. Others mainly guide when, where, and how much certain processes take place. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
CYP7B1Gene function
What if the gene works
The CYP7B1 gene helps your body turn cholesterol byproducts into bile acids, which support fat digestion. It also helps process some steroid substances in the brain and nerves.
Risk
What if the gene does not work
More disruptive variants in the CYP7B1 gene can cause leg stiffness and weakness that worsen over time or, more rarely, liver disease in infancy linked to bile acid problems. Milder variants may cause later onset or less marked features.
Treatment
What does that mean for your treatment
For liver disease caused by loss of function in the CYP7B1 gene, treatment can include primary bile acid replacement, usually cholic acid and sometimes chenodeoxycholic acid in specialist care. For the spastic paraplegia form, no drug tailored to the CYP7B1 gene is established, and bile acid or cholesterol lowering approaches are still being studied.
Conditions associated with CYP7B1
Gene function
What if the gene works
Your body uses the CYP7B1 gene to process certain cholesterol-derived molecules as part of everyday fat handling. Its protein helps turn these molecules into forms that can be used to make bile acids. Understanding how the CYP7B1 gene works in the body makes its role in digestion and cholesterol balance easier to see.
One of the main jobs of the CYP7B1 gene is to help convert cholesterol byproducts into bile acids. Bile acids help your body absorb fats from food and give the liver a route to remove excess cholesterol.
Its protein changes oxysterols, which are cholesterol-derived molecules that also act as body signals. This helps keep these molecules in a useful range and moves them along for further processing.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and help create normal human differences, such as appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CYP7B1 gene can change the enzyme’s shape, stability, or active site, so it works less well or not at all. Some CYP7B1 gene variants leave partial activity, while more severe variants can truncate the protein or cause it to break down early, leading to a larger buildup of certain cholesterol byproducts inside cells. In CYP7B1-related conditions, this often influences how early symptoms appear and how marked they may be.
How variants are linked to conditions
Among variants in the CYP7B1 gene linked to conditions, pathogenic variants can cause hereditary spastic paraplegia type 5A, an inherited condition that often leads to gradually increasing leg stiffness, weakness, and walking difficulty. They can also cause congenital bile acid synthesis defect type 3, a rare liver condition that may appear in infancy or childhood with cholestasis and poor growth. A common finding on broad testing does not by itself confirm either diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widespread in the general population. Most do not directly affect health and instead reflect normal human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors contribute. In some situations, though, a single well characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't broadly confirmed evidence on specific factors that increase or reduce risk related to the CYP7B1 gene. In families with disease-causing CYP7B1 changes, risk is mainly shaped by the inherited variant itself, and a doctor or genetic counselor can help explain personal and family risk.
Inheritance of CYP7B1 variants
Variants in the CYP7B1 gene are inherited in an autosomal recessive pattern. This means a person usually needs to inherit two altered copies of the CYP7B1 gene, one from each parent, to have a CYP7B1-related condition. Parents who each carry one variant are often unaffected carriers, and with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with two working copies. This inheritance of CYP7B1 gene variants applies to the well-established conditions linked to this gene.
What does my CYP7B1 result mean for my family?
For CYP7B1, family impact is usually in line with a recessive pattern. This means brothers and sisters of an affected person may also be affected or may be healthy carriers, and parents are often carriers without symptoms. Other close relatives may also carry the family’s CYP7B1 change, so the result can matter beyond one person.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a CYP7B1 variant, CYP7B1 genetic testing examines DNA from a blood sample, saliva, or a cheek swab. The lab reads the CYP7B1 gene and checks for changes linked with known conditions. Results may show a variant linked to disease, a harmless variant, or one whose meaning is still unclear.
When should I consider getting a genetic test?
Consider CYP7B1 testing if there is a family history of an inherited condition that causes leg stiffness and walking problems, or if someone has unexplained, slowly worsening stiffness and weakness in the legs. It can also be relevant in babies or children with unexplained liver disease linked to problems making bile acids.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but how much it explains depends on the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is most helpful when considered alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, it can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the bloodstream, or responds at its target. This helps explain why the same medication may work well for one person, do little for another, or cause more side effects in someone else. These differences are common and are one of several reasons treatment response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect the way they respond to medications. By studying links between genes and drugs, it helps explain why the same treatment may work differently in different people. For many medicines, genes can influence how powerfully a drug works or how the body handles it. This information can support more informed, more personalized treatment decisions. More detail is available in the LearnHub.
Drugs influenced by the CYP7B1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choice or dose, so general questions about medicines or side effects are best discussed with your doctor. Research on the CYP7B1 gene has looked at body pathways that handle hormones and cholesterol, but this has not become routine prescribing guidance.
History
Researchers identified the CYP7B1 gene in the late 1990s while studying enzymes involved in cholesterol and bile acid pathways. Building on this early work, scientists uncovered more about the gene. In the early 2000s, variants in the CYP7B1 gene were linked to a form of inherited walking difficulty now called spastic paraplegia type 5, which helped connect laboratory findings with a recognizable clinical condition. Around the same time, other CYP7B1 gene variants were tied to a rare bile acid synthesis condition in infants. Over time, these discoveries established the CYP7B1 gene as important in both neurology and metabolic medicine.